Risk factors for severe postoperative complications after left colectomy: A multicenter, retrospective study
Surgery Today · 2026-07 · 56 (7) · 1169-1174
DOI: 10.1007/s00595-025-03228-2 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Surgery Today, online erschienen am 05.01.2026. Verfasst von Keizaburo Maruyama und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Sasebo Chuo Hospital, 15 Yamatocho, Nagasaki, 857-8511, Japan. Hauptthemen laut MEDLINE: Colectomy, Postoperative Complications, Laparoscopy, Colonic Neoplasms. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: The efficacy of laparoscopic surgery for left-sided colon cancer requiring splenic flexure mobilization is still unknown. This study investigates the risk factors for severe postoperative complications in patients undergoing laparoscopic left colectomy. METHODS: The subjects of this retrospective study were 353 consecutive patients who underwent laparoscopic left colectomy across seven participating hospitals between January, 2016 and December, 2024. Patients were divided into two groups according to the development of postoperative complications (POCs): a POC group (n = 70) and a non-POC group (n = 283). Severe POCs developed in 25 patients. RESULTS: The POC group included more female patients (71.4% vs. 51.6%, p = 0.003), more patients with poor performance status (p = 0.005), more patients with combined resection of adjacent organ (14.3% vs. 4.6%, p = 0.006), and more patients with distant metastases (22.9% vs. 10.6%, p = 0.002). The hospital stay was also significantly longer for the POC group patients (18 days vs. 11 days, p < 0.001). Multivariate analysis for severe complications identified that blood loss greater than 50 mL (odds ratio [OR] 2.820, 95% confidence interval [CI] 1.195–6.654; p = 0.017) and distant metastases (OR 2.671, 95%CI 1.021–6.987; p = 0.045) were independent predictors of severe POCs. CONCLUSIONS: Blood loss and distant metastases were risk factors for severe POCs after laparoscopic left colectomy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Sasebo Chuo Hospital, 15 Yamatocho, Nagasaki, 857-8511, Japan.
- Division of Surgical Oncology, Department of Surgery, Nagasaki University Graduate School of Biomedical Science, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
- Colorectal Surgery, Department of Surgery, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
- Department of Surgery, Sasebo City General Hospital, 9-3 Hirasemachi, Nagasaki, 857- 8511, Japan.
- Department of Surgery, National Hospital Organization Nagasaki Medical Center, 1-1001- 1, Omura, Nagasaki, 856-8562, Japan.
- Department of Surgery, Isahaya General Hospital, 24-1, Isahaya, Nagasaki, 854-8501, Japan.
Zitieren
APA
Maruyama, K., Noda, K., Tominaga, T., Hashimoto, S., Tei, S., Ono, R., Hisanaga, M., Oishi, K., Inao, A., Moriyama, M., Uchida, F., Shiraishi, T., Kunizaki, M., Nonaka, T., & Matsumoto, K. (2026). Risk factors for severe postoperative complications after left colectomy: A multicenter, retrospective study. Surgery Today, 56(7), 1169-1174. https://doi.org/10.1007/s00595-025-03228-2
Vancouver
Maruyama K, Noda K, Tominaga T, Hashimoto S, Tei S, Ono R, et al. Risk factors for severe postoperative complications after left colectomy: A multicenter, retrospective study. Surgery Today. 2026;56(7):1169-1174. doi:10.1007/s00595-025-03228-2
BibTeX
@article{Maruyama2026,
author = {Maruyama, Keizaburo and Noda, Keisuke and Tominaga, Tetsuro and Hashimoto, Shintaro and Tei, Shoko and Ono, Rika and Hisanaga, Makoto and Oishi, Kaido and Inao, Ayano and Moriyama, Masaaki and Uchida, Fumitake and Shiraishi, Toshio and Kunizaki, Masaki and Nonaka, Takashi and Matsumoto, Keitaro},
title = {Risk factors for severe postoperative complications after left colectomy: A multicenter, retrospective study},
journal = {Surgery Today},
year = {2026},
volume = {56},
number = {7},
pages = {1169--1174},
doi = {10.1007/s00595-025-03228-2}
}
EUVIMED